None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Males whose age are 18<=years old<60 and who work at Production Headquarters, ITOEN, LTD. (2)The person who has vaccination history of hepatitis B is prioritized for the safety of analyst.
Exclusion criteria
Exclusion criteria: (1) Subjects who are with treatment. (2) Subjects who have severe anemia. (3) Subjects who are with allergy to the study foods or meals in the test period. (4) Subjects who are with current or past medical history of gastrointestinal disease, cardiovascular disease, nephritis and others. Subjects who are with severe mental disorder. (5) Subjects who have potential to change the lifestyle in the test period. (6) Smokers. (7) Subjects who regularly intake foods for specified health uses or foods with functional claims. (8) Subjects who regularly intake pharmaceuticals including oriental medicines or dietary supplements. (9) Subjects who are with allergy to pharmaceuticals or foods related to the study foods. (10) Subjects who donated 200mL of blood within the past 1 month, 400mL of blood within the past 3 months, or blood component within the past 2 weeks at the time of this trial. (11) Subjects who are judged to be unsuitable for the test by the medical doctor for the other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pharmacokinetics and metabolism of ingested catechins | — |
Countries
Japan
Contacts
ITO EN, Ltd. Central Research Institute